In prior studies we demonstrated that Wnt5a could enhance the proliferation of CLL cells that expressed ROR1 when added to serum-starved CLL cells co-cultured with IL-4, IL-10, and HeLa cells engineered to express CD154 [10, 16]. The gene discussed is IL4; the disease is B-cell chronic lymphocytic leukemia.